BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  LIB Therapeutics Announce Positive Results from Lerodalcibep 72-Week Open-Label Extension Studies at American Heart Association 2024

  November 18, 2024

   · 

  5 min read
• Press Releases

  Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference

  November 18, 2024

   · 

  11 min read
• Press Releases

  Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

  Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study Episodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing CardiolRx™ into the Phase II/III MAVERIC-2 and the Phase III MAVERIC-3 clinical trials

  November 18, 2024

   · 

  11 min read
• Press Releases

  PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day”

  November 18, 2024

   · 

  5 min read
• Press Releases

  Streck to distribute Ceres NEAT Liquid Biopsy Kit - Streck BCT worldwide

  November 18, 2024

   · 

  2 min read
• Press Releases

  Encora Therapeutics Successfully Completes ULTRE Clinical Trial Evaluating Novel Wrist-Worn Wearable for Essential Tremor

  November 18, 2024

   · 

  2 min read
• Press Releases

  Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024

  November 18, 2024

   · 

  8 min read
• Press Releases

  Opthea Appoints Kathy Connell to Board of Directors

  November 18, 2024

   · 

  6 min read
• Press Releases

  Bio-Path Holdings Reports Third Quarter 2024 Financial Results

  November 18, 2024

   · 

  8 min read